Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

Bilateral atypical femoral fractures after long-term alendronate therapy: a case report.

Bamrungsong T, Pongchaiyakul C.

J Med Assoc Thai. 2010 May;93(5):620-4.

PMID:
20524451
[PubMed - indexed for MEDLINE]
2.

Risk of atypical femoral fracture with long-term use of alendronate (bisphosphonates) : a systemic review of literature.

Agarwal S, Agarwal S, Gupta P, Agarwal PK, Agarwal G, Bansal A.

Acta Orthop Belg. 2010 Oct;76(5):567-71. Review.

PMID:
21138208
[PubMed - indexed for MEDLINE]
3.

Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.

Iwamoto J, Takeda T, Sato Y.

Curr Med Res Opin. 2006 May;22(5):919-28. Review.

PMID:
16709313
[PubMed - indexed for MEDLINE]
4.

Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates.

Nieves JW, Cosman F.

Curr Osteoporos Rep. 2010 Mar;8(1):34-9. doi: 10.1007/s11914-010-0007-2. Review.

PMID:
20425089
[PubMed - indexed for MEDLINE]
5.

Alendronate-related femoral diaphysis fracture--what should be done to predict and prevent subsequent fracture of the contralateral side?

Edwards MH, McCrae FC, Young-Min SA.

Osteoporos Int. 2010 Apr;21(4):701-3. doi: 10.1007/s00198-009-0986-y. Epub 2009 Jun 27. Review.

PMID:
19562241
[PubMed - indexed for MEDLINE]
6.

Etidronate and alendronate in the treatment of postmenopausal osteoporosis.

Beauchesne MF, Miller PF.

Ann Pharmacother. 1999 May;33(5):587-99. Review.

PMID:
10369624
[PubMed - indexed for MEDLINE]
7.

The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.

Fleurence RL, Iglesias CP, Johnson JM.

Pharmacoeconomics. 2007;25(11):913-33. Review.

PMID:
17960951
[PubMed - indexed for MEDLINE]
8.

Aging bone and osteoporosis: strategies for preventing fractures in the elderly.

Ettinger MP.

Arch Intern Med. 2003 Oct 13;163(18):2237-46. Review.

PMID:
14557222
[PubMed - indexed for MEDLINE]
9.

Atraumatic bilateral femur fracture in long-term bisphosphonate use.

Goddard MS, Reid KR, Johnston JC, Khanuja HS.

Orthopedics. 2009 Aug;32(8). pii: orthosupersite.com/view.asp?rID=41933. doi: 10.3928/01477447-20090624-27. Review.

PMID:
19708622
[PubMed - indexed for MEDLINE]
10.

Bisphosphonates for prevention of postmenopausal osteoporosis.

Ravn P.

Dan Med Bull. 2002 Feb;49(1):1-18. Review.

PMID:
11894721
[PubMed - indexed for MEDLINE]
11.

Postmenopausal osteoporosis and alendronate.

Pérez-López FR.

Maturitas. 2004 Jul 15;48(3):179-92. Review.

PMID:
15207883
[PubMed - indexed for MEDLINE]
12.

[Calcium pros and cons: long term use of bisphosphonates. Bisphosphonates should be used for postmenopausal osteoporosis for a long term].

Soen S.

Clin Calcium. 2011 Oct;21(10):1543-6. doi: CliCa111015431546. Review. Japanese.

PMID:
21960242
[PubMed - indexed for MEDLINE]
13.

Atypical subtrochanteric fractures after long-term bisphosphonate therapy.

Czerwiński E.

Endokrynol Pol. 2011 Jan-Feb;62(1):84-7. Review.

PMID:
21365585
[PubMed - indexed for MEDLINE]
Free Article
14.

[Treatment of osteoporosis by risedronate-- speed, efficacy and safety].

Giljević Z, Vlak T.

Reumatizam. 2006;53(2):66-71. Review. Croatian.

PMID:
17580558
[PubMed - indexed for MEDLINE]
15.

[New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?].

Yamaguchi T, Sugimoto T.

Clin Calcium. 2009 Jan;19(1):38-43. doi: CliCa09013843. Review. Japanese.

PMID:
19122263
[PubMed - indexed for MEDLINE]
16.

Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.

Bilezikian JP.

Am J Med. 2009 Feb;122(2 Suppl):S14-21. doi: 10.1016/j.amjmed.2008.12.003. Review.

PMID:
19187808
[PubMed - indexed for MEDLINE]
17.

Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: a comparative review.

Kherani RB, Papaioannou A, Adachi JD.

Drug Saf. 2002;25(11):781-90. Review.

PMID:
12222989
[PubMed - indexed for MEDLINE]
18.

Osteoporosis: trials and tribulations.

Seeman E.

Am J Med. 1997 Aug 18;103(2A):74S-87S; discussion 87S-89S. Review.

PMID:
9302899
[PubMed - indexed for MEDLINE]
19.

Looking beyond low bone mineral density: multiple insufficiency fractures in a woman with post-menopausal osteoporosis on alendronate therapy.

Lee P, van der Wall H, Seibel MJ.

J Endocrinol Invest. 2007 Jul-Aug;30(7):590-7. Review.

PMID:
17848842
[PubMed - indexed for MEDLINE]
20.

[Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis].

Iwamoto J.

Clin Calcium. 2010 Mar;20(3):396-407. doi: CliCa1003396407. Review. Japanese.

PMID:
20190370
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk